SCHEMBL27414872

SCHEMBL27414872

C=C(C)c1cccc2cccc(Cl)c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
KMT2A Q03164 4/20 0.44
TSHR P16473 3/20 0.44
HSD17B10 Q99714 3/20 0.44
MEN1 O00255 3/20 0.44
KDM4E B2RXH2 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
CNR2 P34972 4/20 0.38
CNR1 P21554 3/20 0.38
CYP1A2 P05177 2/20 0.37
CYP2A6 P11509 1/20 0.37
CLCN2 P51788 1/20 0.36
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
GAA P10253 2/20 0.35
PTK2B Q14289 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
CYP1A1 P04798 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30226846 0.87 HSD17B10 (0.41) ALDH1A1KMT2ATSHRHSD17B10MEN1
SCHEMBL1041519 0.87 HSD17B10 (0.41) ALDH1A1KMT2ATSHRHSD17B10MEN1
SCHEMBL24681050 0.80 MEN1 (0.39) ALDH1A1KMT2ATSHRHSD17B10MEN1
SCHEMBL1506777 0.79 MAPT (0.45) ALDH1A1KMT2ATSHRHSD17B10MEN1
SCHEMBL24970183 0.79 ALDH1A1 (0.53) ALDH1A1KMT2ATSHRHSD17B10MEN1
SCHEMBL17813702 0.79 HSD17B10 (0.40) ALDH1A1KMT2ATSHRHSD17B10MEN1
SCHEMBL9824909 0.78 TSHR (0.54) ALDH1A1TSHRCYP1A2CLCN2CES2
SCHEMBL1028918 0.78 CES2 (0.52) ALDH1A1KMT2ATSHRCYP1A2CLCN2
SCHEMBL25248681 0.78 JAK2 (0.39) ALDH1A1KMT2ATSHRHSD17B10MEN1
SCHEMBL7764568 0.78 CNR1 (0.39) ALDH1A1KMT2ATSHRHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024138206-A1 FLUOROPYRIDOPYRIMIDINE AND FLUOROQUINAZOLINE DERIVATIES AND METHODS OF USE THEREOF FRONTIER MEDICINES CORPORATION (US) 2024-06-27 WO disclosed